BHST
Bioharvest Sciences Inc
$
12.650
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
12.800
Open
11.600
VWAP
12.11
Vol
131.34K
Mkt Cap
--
Low
11.1438
Amount
1.59M
EV/EBITDA(TTM)
--
Total Shares
--
EV
210.11M
EV/OCF(TTM)
--
P/S(TTM)
5.28
BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Show More
4 Analyst Rating
8.06% Upside
Wall Street analysts forecast BHST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BHST is 13.67 USD with a low forecast of 12.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
8.06% Upside
Current: 12.650
Low
12.00
Averages
13.67
High
15.00
8.06% Upside
Current: 12.650
Low
12.00
Averages
13.67
High
15.00
The End
No Data
Valuation Metrics
The current forward P/E ratio for Bioharvest Sciences Inc (BHST.O) is -42.64, compared to its 5-year average forward P/E of -24.14. For a more detailed relative valuation and DCF analysis to assess Bioharvest Sciences Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-24.14
Current PE
-42.64
Overvalued PE
-15.74
Undervalued PE
-32.53
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
577.01
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1620.62
Undervalued EV/EBITDA
-466.60
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
2.85
Current PS
0.00
Overvalued PS
3.47
Undervalued PS
2.24
Financials
Annual
Quarterly
FY2025Q2
YoY :
+41.28%
8.52M
Total Revenue
FY2025Q2
YoY :
+2.20%
-1.82M
Operating Profit
FY2025Q2
YoY :
+493.89%
-4.08M
Net Income after Tax
FY2025Q2
YoY :
+500.00%
-0.24
EPS - Diluted
FY2025Q2
YoY :
-23.18%
-2.05M
Free Cash Flow
FY2025Q2
YoY :
+16.05%
59.73
Gross Profit Margin - %
FY2025Q2
YoY :
+320.35%
-47.92
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
BHST News & Events
News
9.5
08-15Yahoo FinanceBioHarvest Sciences Second Quarter 2025 Earnings: EPS Misses Expectations
9.5
08-13NewsfilterDiamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST)
9.5
05-21NewsfilterDiamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST)
Sign Up For More News
People Also Watch
MSFT
Microsoft Corp
524.850
USD
+0.17%
AMZN
Amazon.com Inc
225.220
USD
+1.55%
META
Meta Platforms Inc
717.840
USD
+0.67%
TSLA
Tesla Inc
438.690
USD
+1.29%
NVDA
NVIDIA Corp
189.110
USD
+2.20%
AAPL
Apple Inc
258.060
USD
+0.62%
WMT
Walmart Inc
102.900
USD
-0.33%
AVGO
Broadcom Inc
345.500
USD
+2.70%
XOM
Exxon Mobil Corp
114.020
USD
-0.21%
ORCL
Oracle Corp
288.630
USD
+1.54%
FAQ
What is Bioharvest Sciences Inc (BHST) stock price today?
The current price of BHST is 12.65 USD — it has increased 8.4 % in the last trading day.
What is Bioharvest Sciences Inc (BHST)'s business?
What is the price predicton of BHST Stock?
What is Bioharvest Sciences Inc (BHST)'s revenue for the last quarter?
What is Bioharvest Sciences Inc (BHST)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Bioharvest Sciences Inc (BHST)'s fundamentals?
How many employees does Bioharvest Sciences Inc (BHST). have?